- Home
- News
- Drug Discovery
Nonprofit under pressure to make new TB drug affordable
Authorities warn that antibiotic-resistant infections rank high, if not at the top, of public and global health concerns. TB offers a prime...Roche cancer drug the 3rd approved for pan-tumor use
Aimed at the molecular catalysts of tumor growth, targeted therapies are treatment mainstays across a wide range of cancer types.Novo faces shareholder suit over insulin sales disclosures
Novo is best known for its insulin products like Levemir (insulin detemir) and Tresiba (insulin degludec), as well as other diabetes treatments...Celgene wins approval for drug key to Bristol buyout
Approval of Inrebic, which was previously known as fedratinib, is the first domino to fall in Bristol-Myers bet on Celgene's product pipeline.
- Forum
- RXM TV
- Register
- Home
- News
- Drug Discovery
Nonprofit under pressure to make new TB drug affordable
Authorities warn that antibiotic-resistant infections rank high, if not at the top, of public and global health concerns. TB offers a prime...Roche cancer drug the 3rd approved for pan-tumor use
Aimed at the molecular catalysts of tumor growth, targeted therapies are treatment mainstays across a wide range of cancer types.Novo faces shareholder suit over insulin sales disclosures
Novo is best known for its insulin products like Levemir (insulin detemir) and Tresiba (insulin degludec), as well as other diabetes treatments...Celgene wins approval for drug key to Bristol buyout
Approval of Inrebic, which was previously known as fedratinib, is the first domino to fall in Bristol-Myers bet on Celgene's product pipeline.
- Forum
- RXM TV
- Register
- Home
- News
- Drug Discovery
Nonprofit under pressure to make new TB drug affordable
Authorities warn that antibiotic-resistant infections rank high, if not at the top, of public and global health concerns. TB offers a prime...Roche cancer drug the 3rd approved for pan-tumor use
Aimed at the molecular catalysts of tumor growth, targeted therapies are treatment mainstays across a wide range of cancer types.Novo faces shareholder suit over insulin sales disclosures
Novo is best known for its insulin products like Levemir (insulin detemir) and Tresiba (insulin degludec), as well as other diabetes treatments...Celgene wins approval for drug key to Bristol buyout
Approval of Inrebic, which was previously known as fedratinib, is the first domino to fall in Bristol-Myers bet on Celgene's product pipeline.
- Forum
- RXM TV
- Register
